Pharmacy Society of Wisconsin
Registered Principal Details
Business Or Interest:
Pharmacy, heath care
Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy businesses, medication usage, medication costs, prescription drug use, and the practice of pharmacy.
CEO Name:
Christopher Decker
Vice President of Public Affairs
Pharmacy, heath care
Lobbying Interests:
Issues affecting pharmacists, pharmacy technicians, pharmacy students, pharmacy businesses, medication usage, medication costs, prescription drug use, and the practice of pharmacy.
CEO Name:
Christopher Decker
Vice President of Public Affairs
Contact
DMW
Danielle M Womack
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org
701 Heartland Trail
Madison, WI 53717
(608) 827-9200
dwomack@pswi.org
http://www.pswi.org
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
January 2017 Special Session Assembly Bill 4
Relating to: prohibiting certain schedule V controlled substances from being dispensed without a prescription.
Bill Text and History
2017 Wisconsin Act 25
2/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting certain schedule V controlled substances from being dispensed without a prescription.
Bill Text and History
2017 Wisconsin Act 25
For
Notification Date2/20/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
January 2017 Special Session Senate Bill 4
Relating to: prohibiting certain schedule V controlled substances from being dispensed without a prescription.
Bill Text and History
2/22/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prohibiting certain schedule V controlled substances from being dispensed without a prescription.
Bill Text and History
For
Notification Date2/22/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 69
Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.
Bill Text and History
3/1/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: access to investigational drugs, devices, and biological products and limitations on liability related to their use.
Bill Text and History
None
Notification Date3/1/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 96
Relating to: supply and use of epinephrine auto-injectors by certain authorized individuals. (FE)
Bill Text and History
2017 Wisconsin Act 133
3/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: supply and use of epinephrine auto-injectors by certain authorized individuals. (FE)
Bill Text and History
2017 Wisconsin Act 133
For
Notification Date3/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 125
Relating to: prescription order extensions for when a refill authorization cannot be obtained.
Bill Text and History
2017 Wisconsin Act 19
3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prescription order extensions for when a refill authorization cannot be obtained.
Bill Text and History
2017 Wisconsin Act 19
For
Notification Date3/7/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 182
Relating to: various changes to the pharmacy practice law and modifying rules promulgated by the Pharmacy Examining Board.
Bill Text and History
3/29/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: various changes to the pharmacy practice law and modifying rules promulgated by the Pharmacy Examining Board.
Bill Text and History
For
Notification Date3/29/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 252
Relating to: administration of vaccines by pharmacy students.
Bill Text and History
4/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: administration of vaccines by pharmacy students.
Bill Text and History
For
Notification Date4/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 306
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
2017 Wisconsin Act 98
5/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
2017 Wisconsin Act 98
Other
Notification Date5/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 335
Relating to: fentanyl analogs and providing a criminal penalty.
Bill Text and History
2017 Wisconsin Act 60
9/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: fentanyl analogs and providing a criminal penalty.
Bill Text and History
2017 Wisconsin Act 60
For
Notification Date9/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 444
Relating to: hospice staff transferring the controlled substances of deceased persons to drug disposal programs.
Bill Text and History
2017 Wisconsin Act 99
8/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: hospice staff transferring the controlled substances of deceased persons to drug disposal programs.
Bill Text and History
2017 Wisconsin Act 99
For
Notification Date8/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 576
Relating to: using a tribal identification card for various purposes.
Bill Text and History
10/25/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: using a tribal identification card for various purposes.
Bill Text and History
For
Notification Date10/25/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 608
Relating to: delegation of the practice of pharmacy and granting rule-making authority.
Bill Text and History
2017 Wisconsin Act 293
10/30/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: delegation of the practice of pharmacy and granting rule-making authority.
Bill Text and History
2017 Wisconsin Act 293
For
Notification Date10/30/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 621
Relating to: registration of pharmacy benefit managers, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
2/12/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: registration of pharmacy benefit managers, granting rule-making authority, and providing a penalty. (FE)
Bill Text and History
For
Notification Date2/12/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 679
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
12/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
None
Notification Date12/13/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 680
Relating to: pharmacists and pharmacy students administering vaccines.
Bill Text and History
1/2/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: pharmacists and pharmacy students administering vaccines.
Bill Text and History
For
Notification Date1/2/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 876
Relating to: coverage of prescription eye drop refills.
Bill Text and History
2017 Wisconsin Act 305
2/1/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: coverage of prescription eye drop refills.
Bill Text and History
2017 Wisconsin Act 305
For
Notification Date2/1/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 902
Relating to: wholesale distributors subject to Pharmacy Examining Board requirements and enforcement and disciplinary authority of the Department of Safety and Professional Services and attached boards and credentialing boards. (FE)
Bill Text and History
2017 Wisconsin Act 328
2/7/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: wholesale distributors subject to Pharmacy Examining Board requirements and enforcement and disciplinary authority of the Department of Safety and Professional Services and attached boards and credentialing boards. (FE)
Bill Text and History
2017 Wisconsin Act 328
For
Notification Date2/7/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 1072
Relating to: federal government waivers and other requests for federal approval; public assistance programs; waivers from work search and registration requirements for certain unemployment insurance benefit claimants; granting rule-making authority; and ma...
Bill Text and History
12/4/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: federal government waivers and other requests for federal approval; public assistance programs; waivers from work search and registration requirements for certain unemployment insurance benefit claimants; granting rule-making authority; and ma...
Bill Text and History
Against
Notification Date12/4/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Assembly Bill 1073
Relating to: legislative power and duties, state agency and authority composition and operations, administrative rule-making process, federal government waivers and approvals, unemployment insurance work search and registration requirements, and making an ...
Bill Text and History
12/4/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: legislative power and duties, state agency and authority composition and operations, administrative rule-making process, federal government waivers and approvals, unemployment insurance work search and registration requirements, and making an ...
Bill Text and History
Against
Notification Date12/4/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 116
Relating to: prescription order extensions for when a refill authorization cannot be obtained.
Bill Text and History
3/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: prescription order extensions for when a refill authorization cannot be obtained.
Bill Text and History
For
Notification Date3/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 126
Relating to: various changes to the pharmacy practice law and modifying rules promulgated by the Pharmacy Examining Board.
Bill Text and History
2017 Wisconsin Act 18
3/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: various changes to the pharmacy practice law and modifying rules promulgated by the Pharmacy Examining Board.
Bill Text and History
2017 Wisconsin Act 18
For
Notification Date3/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 172
Relating to: administration of vaccines by pharmacy students.
Bill Text and History
2017 Wisconsin Act 42
4/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: administration of vaccines by pharmacy students.
Bill Text and History
2017 Wisconsin Act 42
For
Notification Date4/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 209
Relating to: supply and use of epinephrine auto-injectors by certain authorized individuals. (FE)
Bill Text and History
10/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: supply and use of epinephrine auto-injectors by certain authorized individuals. (FE)
Bill Text and History
For
Notification Date10/17/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 237
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
8/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: tracking the sale of pseudoephedrine products.
Bill Text and History
Other
Notification Date8/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 262
Relating to: fentanyl analogs and providing a criminal penalty.
Bill Text and History
9/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: fentanyl analogs and providing a criminal penalty.
Bill Text and History
For
Notification Date9/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 263
Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE)
Bill Text and History
5/30/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE)
Bill Text and History
Against
Notification Date5/30/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 361
Relating to: hospice staff transferring the controlled substances of deceased persons to drug disposal programs.
Bill Text and History
8/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: hospice staff transferring the controlled substances of deceased persons to drug disposal programs.
Bill Text and History
For
Notification Date8/24/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 488
Relating to: using a tribal identification card for various purposes.
Bill Text and History
2017 Wisconsin Act 226
10/30/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: using a tribal identification card for various purposes.
Bill Text and History
2017 Wisconsin Act 226
For
Notification Date10/30/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 533
Relating to: delegation of the practice of pharmacy and granting rule-making authority.
Bill Text and History
11/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: delegation of the practice of pharmacy and granting rule-making authority.
Bill Text and History
For
Notification Date11/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 575
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
Bill Text and History
2017 Wisconsin Act 149
None
Notification Date11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 576
Relating to: pharmacists and pharmacy students administering vaccines.
Bill Text and History
11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: pharmacists and pharmacy students administering vaccines.
Bill Text and History
For
Notification Date11/21/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 750
Relating to: wholesale distributors subject to Pharmacy Examining Board requirements and enforcement and disciplinary authority of the Department of Safety and Professional Services and attached boards and credentialing boards. (FE)
Bill Text and History
2/7/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: wholesale distributors subject to Pharmacy Examining Board requirements and enforcement and disciplinary authority of the Department of Safety and Professional Services and attached boards and credentialing boards. (FE)
Bill Text and History
For
Notification Date2/7/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 771
Relating to: coverage of prescription eye drop refills.
Bill Text and History
2/7/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Relating to: coverage of prescription eye drop refills.
Bill Text and History
For
Notification Date2/7/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Budget Bill Subjects
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide
Health Services: Departmentwide
Notification Date
3/15/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/15/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Health Services: Medicaid Services
Health Services: Medicaid Services
Notification Date
3/14/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/14/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Biennial budget bill treatment of matter relating to
Safety and Professional Services: Departmentwide
Safety and Professional Services: Departmentwide
Notification Date
3/15/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
3/15/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Administrative Rulemaking Proceedings
Agency Name
Controlled Substances Board (CSB)
Subject
Operation of the Prescription Drug Monitoring Program
Scope Statement
SS 103_15
1/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Controlled Substances Board (CSB)
Subject
Operation of the Prescription Drug Monitoring Program
Scope Statement
SS 103_15
None
Notification Date1/9/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Administration of drug products and devices other than vaccines
Scope Statement
SS 032_16
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Administration of drug products and devices other than vaccines
Scope Statement
SS 032_16
For
Notification Date12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Operation of the prescription drug monitoring program
Scope Statement
SS 034_15
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Operation of the prescription drug monitoring program
Scope Statement
SS 034_15
None
Notification Date12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Pharmacy practice.
Scope Statement
Register Number: 691 (7/15/2013)
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Pharmacy practice.
Scope Statement
Register Number: 691 (7/15/2013)
None
Notification Date12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
Agency Name
Pharmacy Examining Board (Phar)
Subject
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
Scope Statement
Register Number: 683 (11/15/2012)
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Pharmacy Examining Board (Phar)
Subject
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
Scope Statement
Register Number: 683 (11/15/2012)
None
Notification Date12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
NAIC Health Carrier Prescription Drug Benefit Management Model Act
NAIC Health Carrier Prescription Drug Benefit Management Model Act
Action Intended To Affect
Both Legislative matter and rule
Notification Date
6/7/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
6/7/2018
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters relating to medication counseling
Matters relating to medication counseling
Action Intended To Affect
Both Legislative matter and rule
Notification Date
5/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
5/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters relating to the Unfair Sales Act
Matters relating to the Unfair Sales Act
Action Intended To Affect
Both Legislative matter and rule
Notification Date
5/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
5/16/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
LRB 0994- relating to prescription order extensions for when a refill authorization cannot be obtained
Development, drafting or introduction of a proposal relating to
LRB 0994- relating to prescription order extensions for when a refill authorization cannot be obtained
LRB 0994- relating to prescription order extensions for when a refill authorization cannot be obtained
Action Intended To Affect
Legislative matter
Notification Date
2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
2/8/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to scheduling of controlled substances
Matters related to scheduling of controlled substances
Action Intended To Affect
Both Legislative matter and rule
Notification Date
2/2/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
2/2/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacist and pharmacy intern delivery and reimbursement for immunization services
Pharmacist and pharmacy intern delivery and reimbursement for immunization services
Action Intended To Affect
Both Legislative matter and rule
Notification Date
1/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
1/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacist dispensing of emergency refills
Pharmacist dispensing of emergency refills
Action Intended To Affect
Legislative matter
Notification Date
1/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Legislative matter
Notification Date
1/5/2017
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Medicaid reimbursement and audits
Medicaid reimbursement and audits
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacy and pharmacist regulations
Pharmacy and pharmacist regulations
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacist delegation of services
Pharmacist delegation of services
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/15/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters relating to pharmacy networks and specialty pharmacy networks
Matters relating to pharmacy networks and specialty pharmacy networks
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Administration of non-vaccine injections
Administration of non-vaccine injections
Action Intended To Affect
Rule (by a state agency)
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Rule (by a state agency)
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacy Administrative Code
Pharmacy Administrative Code
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Pharmacy Benefit Managers
Pharmacy Benefit Managers
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Development, drafting or introduction of a proposal relating to
Matters related to pharmacist delivery of services
Matters related to pharmacist delivery of services
Action Intended To Affect
Both Legislative matter and rule
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Both Legislative matter and rule
Notification Date
12/2/2016
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Total Lobbying Effort
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2017 January - June $34,909.94 |
2017 July - December $42,191.16 |
2018 January - June $61,880.23 |
2018 July - December $29,834.53 |
Total $168,815.86 |
| Total Hours Communicating | 2017 January - June 195.00 |
2017 July - December 77.75 |
2018 January - June 75.75 |
2018 July - December 44.75 |
Total 393.25 |
| Total Hours Other | 2017 January - June 303.25 |
2017 July - December 256.75 |
2018 January - June 492.25 |
2018 July - December 281.75 |
Total 1334.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
Relating to: prohibiting certain schedule V controlled substances from being dispensed without a prescription.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 2% |
2017 July - December |
2018 January - June |
2018 July - December |
Total < 1% |
Relating to: tracking the sale of pseudoephedrine products.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 5% |
2017 July - December 1% |
2018 January - June |
2018 July - December |
Total 2% |
Relating to: administration of vaccines by pharmacy students.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 10% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 3% |
Relating to: regulating the sale of prescription drugs and other merchandise below cost. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 10% |
2017 July - December 2% |
2018 January - June 5% |
2018 July - December |
Total 5% |
Relating to: various changes to the pharmacy practice law and modifying rules promulgated by the Pharmacy Examining Board.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 15% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 4% |
Relating to: prescription order extensions for when a refill authorization cannot be obtained.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 20% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 6% |
Relating to: supply and use of epinephrine auto-injectors by certain authorized individuals. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 1% |
2018 January - June |
2018 July - December |
Total < 1% |
Relating to: using a tribal identification card for various purposes.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 1% |
2018 January - June 1% |
2018 July - December |
Total < 1% |
Relating to: tracking the sale of pseudoephedrine products.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 1% |
2018 January - June |
2018 July - December |
Total < 1% |
Relating to: using a tribal identification card for various purposes.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 1% |
2018 January - June |
2018 July - December |
Total < 1% |
Relating to: hospice staff transferring the controlled substances of deceased persons to drug disposal programs.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 2% |
2018 January - June |
2018 July - December |
Total < 1% |
Relating to: hospice staff transferring the controlled substances of deceased persons to drug disposal programs.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 2% |
2018 January - June |
2018 July - December |
Total < 1% |
Relating to: pharmacists and pharmacy students administering vaccines.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 5% |
2018 January - June |
2018 July - December |
Total < 1% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 6% |
2018 January - June 1% |
2018 July - December |
Total 2% |
Relating to: the treatment of biological products for various purposes under the pharmacy practice law.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 6% |
2018 January - June |
2018 July - December |
Total 1% |
Relating to: delegation of the practice of pharmacy and granting rule-making authority.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 10% |
2018 January - June 15% |
2018 July - December |
Total 7% |
Relating to: pharmacists and pharmacy students administering vaccines.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 10% |
2018 January - June 20% |
2018 July - December |
Total 9% |
Relating to: delegation of the practice of pharmacy and granting rule-making authority.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 10% |
2018 January - June 3% |
2018 July - December |
Total 3% |
Relating to: coverage of prescription eye drop refills.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 1% |
2018 July - December |
Total < 1% |
Relating to: wholesale distributors subject to Pharmacy Examining Board requirements and enforcement and disciplinary authority of the Department of Safety and Professional Services and attached boards and credentialing boards. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 1% |
2018 July - December |
Total < 1% |
Relating to: wholesale distributors subject to Pharmacy Examining Board requirements and enforcement and disciplinary authority of the Department of Safety and Professional Services and attached boards and credentialing boards. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 1% |
2018 July - December |
Total < 1% |
Relating to: registration of pharmacy benefit managers, granting rule-making authority, and providing a penalty. (FE)
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 5% |
2018 July - December |
Total 2% |
Budget Bill Subjects
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 3% |
2017 July - December 2% |
2018 January - June |
2018 July - December 3% |
Total 2% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 2% |
2018 July - December 5% |
Total 2% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 5% |
2018 July - December 5% |
Total 3% |
Administrative Rulemaking Proceedings
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 2% |
2017 July - December |
2018 January - June |
2018 July - December |
Total < 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 2% |
2017 July - December |
2018 January - June |
2018 July - December |
Total < 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 2% |
2017 July - December 1% |
2018 January - June |
2018 July - December |
Total < 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 2% |
2017 July - December 8% |
2018 January - June 5% |
2018 July - December 25% |
Total 9% |
Repeal and recreate Chapter Phar 15, relating to sterile pharmaceuticals and non-sterile pharmaceuticals.
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 2% |
2017 July - December 25% |
2018 January - June 15% |
2018 July - December |
Total 10% |
Topics Not Yet Assigned A Bill Or Rule Number
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 2% |
2017 July - December |
2018 January - June |
2018 July - December |
Total < 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 3% |
2017 July - December |
2018 January - June 7% |
2018 July - December 10% |
Total 5% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 5% |
2017 July - December |
2018 January - June |
2018 July - December |
Total 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 5% |
2017 July - December 4% |
2018 January - June 8% |
2018 July - December 25% |
Total 10% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June 10% |
2017 July - December |
2018 January - June |
2018 July - December 5% |
Total 4% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December 1% |
2018 January - June 1% |
2018 July - December 3% |
Total 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June 3% |
2018 July - December 4% |
Total 2% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December 5% |
Total < 1% |
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December |
Total |
|---|---|---|---|---|
| 2017 January - June |
2017 July - December |
2018 January - June |
2018 July - December 10% |
Total 2% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
Includes time spent on:
- Gubernatorial nominations
- Matters on which the organization made no lobbying communication